-
Taxonomy & unit
-
us-gaap: GBP/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
TC BioPharm (Holdings) plc quarterly/annual Earnings Per Share, Diluted history and growth rate from Q1 2023 to Q1 2024.
- TC BioPharm (Holdings) plc Earnings Per Share, Diluted for the quarter ending March 31, 2024 was -0.11 GBP/shares, a 64.5% increase year-over-year.
- TC BioPharm (Holdings) plc annual Earnings Per Share, Diluted for 2023 was -0.96 GBP/shares, a 49.7% increase from 2022.
Earnings Per Share, Diluted, Quarterly (GBP/shares)
Earnings Per Share, Diluted, YoY Quarterly Growth (%)